Archive

October 9, 2024

Browsing

Monday saw something of a bloodbath on Wall Street, with the Dow ($INDU) plunging over 500 points at its worst and the S&P 500 ($SPX) and Nasdaq ($COMPQ) falling over 1%.

Higher oil prices, triggered by tensions in the Middle East, played a big hand in Monday’s market mayhem. In the blogosphere, other topics like a historic crude oil short squeeze and fears of a looming Israeli attack on Iranian oil and gas infrastructure made the headlines.

Is it time to go long? With oil spiking, could there be an opportunity to ride the wave with gasoline, given the usual lag? How high could oil climb? And with the current geopolitical tension, could we see a longer uptrend in oil or gas? What levels should you keep an eye on?

Let’s pause and break down what’s happening with oil and gas prices in technical terms.

What’s Going On with Oil Prices?

Below is a weekly chart presenting a five-year lookback on oil, using the US Oil Fund (US) as a proxy.

CHART 1. WEEKLY FIVE-YEAR CHART OF USO. Zooming out a bit, the level of fear in the market might not seem dramatic when you look at price action. USO is trading sideways with clear support and resistance levels.Chart source: StockCharts.com. For educational purposes.

Following the dramatic 2020 drop and 2022 peak, crude oil has traded sideways. The range may have been rather wide, but, directionally, it’s been sideways nevertheless.

  • The magenta rectangle highlights a stabilizing range of support and resistance.
  • Price has moved above and below the 50-week simple moving average (SMA) in a whipsaw fashion.
  • In terms of momentum, the Money Flow Index (MFI) is showing a dip in buying pressure, just like the Chaikin Money Flow (CMF), even with the recent uptick in buying (check out the magenta circle).

The broader structure here shows that the current price surge is still relatively minuscule compared to the structure itself. But that doesn’t mean geopolitical events can’t drive prices above the current resistance level of around $83 or lower to its support at $64.

A close below either level would signal a broader fundamental driver and potentially the beginning of a longer-term trend.

Let’s switch to a daily chart for a more near-term view.

CHART 2. DAILY CHART OF USO. If the price continues higher, there will be a lot more resistance up ahead. Note the multiple support levels as well. These could trigger a price bounce.Chart source: StockCharts.com. For educational purposes.

This might not be unusual for wide long-term trading ranges, but you can spot plenty of ceilings (and floors) ahead.

  • The Relative Strength Index (RSI) is rising and not quite yet at overbought territory, meaning there’s still room to run. But how much higher can it go?
  • Look at the volume spike toward the bottom of the chart. It’s quite significant, but what’s perhaps more critical is the follow-up in volume as well as price, and so far, it isn’t there (yet).
  • The CMF reading doesn’t show anything extraordinary in measuring buying pressure.
  • If you’re curious as to the effect of crude oil prices on the broader energy sector, the energy sector’s Bullish Percent Index (BPI), a breadth indicator, tells us that over 60% of energy stocks are displaying P&F (Point & Figure) buy signals, which is, as you might guess, bullish.

Watch this: Focus on the multiple levels of resistance. Will volume and momentum drive USO beyond these levels? That’s a matter of geopolitical developments, none of which anyone can predict. However, sentiment can drive prices higher even without fundamental validation. And if this happens, it can last beyond the coming election, particularly if the question of an attack on Iranian energy infrastructure remains at the forefront of investors’ minds.

Also, mind the multiple levels of support (see black dotted lines), as several are likely to trigger a bounce.

What’s Going On with Gas Prices?

So, how might the rise in oil prices affect gas prices? Here’s a daily chart of the US Gasoline Fund (UGA) for comparison (UGA will be the proxy for gas).

The answer is, nothing yet.

CHART 3. DAILY PRICE OF UGA. Note the correlation in the indicator window above the chart. It’s showing a 99% correlation between UGA and USO.Chart source: StockCharts.com. For educational purposes.

When it comes to gasoline prices, there are two things to consider:

  • Lag time. There’s a relative lag time between oil prices and gasoline prices. This can take two to four weeks, depending on supply chains, refining processes, and distribution networks.
  • Market sentiment. Futures traders, especially, can push prices up in anticipation of a significant rise in crude oil, disruption to supply chains, refining, and distribution.

If this is what’s happening in UGA, there’s hardly any volume behind the move (see magenta circle). The lack of buying pressure, as displayed by the OnBalance Volume (OBV) indicator, agrees with this.

Another thing to watch: Investors wonder if the recent spike in crude oil will lead to a rise in gas prices. In other words, did crude oil and gasoline temporarily de-correlate? Looking at the StockCharts Correlation Coefficient indicator above the chart, you’ll notice that both commodities are still at a 99% correlation.

So, if you were hoping to take advantage of the lag between gasoline and crude oil prices, then price-wise, it isn’t there as of this moment (according to the indicator).

At the Close

To wrap things up, oil is spiking in the near term. In the bigger picture, however, it’s still trading sideways, and resistance levels are about to be tested. While gas prices usually lag, its price remains correlated to oil’s price surge, and, to date, there’s no significant volume driving it up (unlike crude oil). The big question is whether geopolitical risks will push prices higher. Sentiment can drive up prices even if that means getting ahead of fundamentals. Thus, you should keep an eye on the current technical levels and indicators. You’re likely to see a sharp response in those, as you would in any news item that might cause investors to jump.


Disclaimer: This blog is for educational purposes only and should not be construed as financial advice. The ideas and strategies should never be used without first assessing your own personal and financial situation or without consulting a financial professional.

In this video from StockCharts TV, Julius presents a few conflicting rotations and signals that continue to warrant caution while the S&P 500 keeps hovering just above support. With the negative divergences between price and MACD/RSI remaining intact, SPY should not break 565. Julius looks at rotations in asset classes, growth/value factors, and US sectors to assess the current state of the markets.

This video was originally published on October 8, 2024. Click anywhere on the icon above to view on our dedicated page for Julius.

Past episodes of Julius’ shows can be found here.

#StayAlert, -Julius

Apologies for revisiting Carvana (CVNA), but it has such a beautiful chart pattern playing out the way it should. After bottoming out in a cup with handle pattern on the weekly chart and breaking out of the handle, Carvana stock has been in an upward-moving trend. The stock has now hit another milestone level, making it necessary to feature it again.

Carvana stock hits a new 52-week high and is back in the top position in the StockCharts Technical Rank (SCTR) Report, Top 10, Large Cap category. Several StockCharts Predefined Scans were also triggered for Carvana (see Symbol Summary page for CVNA). The stock price has been trending higher, with higher highs and higher lows. For a while, CVNA has frequently appeared in the top five in the SCTR Report, and if you follow the ChartWatchers blog, you’d have seen the stock pop up frequently. If you opened a long position in CVNA, you’d be feeling pretty good now.

But don’t get too complacent. It’s time to manage your position. Let’s analyze the recent stock price charts, starting with the weekly chart.

Carvana Stock Weekly Analysis

From a weekly perspective, Carvana’s stock price is maintaining its uptrend; it’s also approaching its 50% Fibonacci retracement level, and its relative strength index (RSI) has just crossed the 70 level. The uptrend is still intact and could go much higher if the momentum is behind it.

CHART 1. CARVANA STOCK CONTINUES TRENDING HIGHER. After breaking out of a cup and handle pattern, CVNA is trending higher and is now at its 50% Fibonacci retracement level.Chart source: StockCharts.com. For educational purposes.

I would watch the 50% retracement level carefully. It could act as a resistance level, causing the stock price to stall. As long as it stays within the 38.2 and 50% retracement level, i.e., between $145 and $189.42, the uptrend should be intact. Of course, if CVNA breaks above the 50% retracement level, continue to ride the trend.

Carvana Stock Daily Analysis

When a stock has a well-defined trend, momentum is an important ingredient in fueling the trend higher. The Chaikin Money Flow indicator (top panel) and moving average convergence/divergence (MACD) displayed in the bottom panel show that momentum supports the upmove in Carvana (see daily chart below).

CHART 2. DAILY CHART OF CARVANA STOCK. The stock broke out of its upward channel with rising CMF and MACD. It closed above $189.42. Will it push through and surge higher?Chart source: StockCharts.com. For educational purposes.

Carvana stock has broken out of its upward price channel. Instead of using the 21-day exponential moving average (EMA), I have shortened the period to a 5-day one to use as a trailing stop. I’ve also changed the longer-term simple moving average to a 25-period one.

The bottom line. Add the daily and weekly charts of CVNA to your StockCharts ChartLists and continue to monitor them. Set a StockCharts Alert to notify you when CVNA crosses below its 5-day EMA using the Advanced Alerts tool. If you’ve decided to unload some positions when price crosses below the 5-day EMA, follow your system. Making objective trading decisions can keep emotions at bay, which is a good habit to cultivate.



Disclaimer: This blog is for educational purposes only and should not be construed as financial advice. The ideas and strategies should never be used without first assessing your own personal and financial situation, or without consulting a financial professional.

Feneck laid out and discussed five points investors should consider when evaluating a junior mining company in order of importance: management, project, jurisdiction, share structure and management ownership.

On the topic of jurisdiction, Feneck said he is paying close attention to several silver companies in Mexico that have open-pit projects but are awaiting permits.

Some of the companies awaiting government approvals are Silver Tiger (TSXV:SLVR,OTCQX:SLVTF), Sonoro Gold (TSXV:SGO,OTCQB:SMOFF) and Discovery Silver (TSXV:DSV,OTCQX:DSVSF).

“All three of those are waiting on the new person in charge, (President) Sheinbaum, to give them direction in October as to how things are going to roll going forward,” Feneck said. ‘So the stock prices of these companies have been very depressed as a result of investors waiting.’

While the outcome is still unknown, his firm performed due diligence by reaching out to the companies to get their thoughts on the situation and their backup plans.

The conversation later turned to knowing when to enter and how much to invest in new plays.

“My process is different than just about everyone that I’ve talked to in that we admit that we can’t get it correct all the time on the entry point … Therefore, we buy (into a given stock) six to 10 times over a given year, usually,” he said.

These purchases are typically in the US$5,000 range as opposed to US$50,000 because he doesn’t want to move the stock too much upon entry and he wants those that follow him to be able to enter as well.

Watch the interview above for more from Feneck, including other stocks that stand out to him and which strategies he uses to know when it’s time to sell.

Interview by Charlotte McLeod. Article by Georgia Williams.

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

Securities Disclosure: I, Georgia Williams, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) has traded at three-year highs in 2024 in response to looming interest rate cuts, breakthrough innovations and increased deals in the space.

After dropping to a low of 3,637.05 in October 2023, the index climbed to start 2024 at 4,457.02. It did hit a bump in the road early in Q2 when it plunged to 4,056.3 in April, but it quickly recovered and has since tracked even higher, reaching a high of 4,954.813 on September 19.

While the current economic environment means the biotech sector may have a complex road ahead, robust growth could be in store in the future.

According to a recent report from Precedence Research, the global biotech market is expected to grow at a compound annual growth rate of 11.5 percent from now to 2034, reaching a valuation of US$4.61 trillion.

Driving that growth will be favorable government policies, investment in the sector, increased demand for synthetic biology and a rise in chronic disorders such as cancer, heart disease and hypertension.

The top NASDAQ biotech stocks have seen sizeable share price increases this year. For those interested in investing in biotech companies, the best-performing biotech stocks are outlined below.

Data was gathered on October 4, 2024, using TradingView’s stock screener, and all best-performing biotech stocks had market caps between US$50 million and US$500 million at that time.

1. Instil Bio (NASDAQ:TIL)

Company Profile

Year-to-date gain: 465.93 percent
Market cap: US$315.37 million
Share price: US$48.49

Clinical-stage biopharmaceutical company Instil Bio is developing a pipeline of oncology therapies. The company’s primary asset is IMM2510, a differentiated PD-L1xVEGF bispecific antibody aimed at the treatment of multiple solid tumor cancers.

Instil Bio has a definitive agreement for the in-licensing, ex-China development and commercial rights to IMM2510 from China-based ImmuneOnco Biopharmaceuticals (HKEX:1541). The agreement also covers another drug candidate in its pipeline, IMM27M, a next-generation anti-CTLA-4 antibody targeting multiple solid tumors.

In July, the company secured a 15-year lease agreement with AstraZeneca Pharmaceuticals (LSE:AZN) for a cell therapy manufacturing facility based in the United States.

“By executing a 15-year lease of our Tarzana cell therapy manufacturing facility, we have strengthened our financial foundation to support Instil’s near-term clinical development of these assets,” said Instil Bio CEO Bronson Crouch.

In mid-September, Instil Bio and ImmuneOnco announced a global registrational strategy for IMM2510 in combination with chemotherapy in treating non-small cell lung cancer and triple-negative breast cancer. The strategy includes a series of clinical trials to be launched both in the US and China in late 2024 and early 2025.

Instil Bio’s stock surged in September to reach a year-to-date high of US$92.00 on the 13th of the month.

2. Rezolute Bio (NASDAQ:RZLT)

Company Profile

Year-to-date gain: 408.25 percent
Market cap: US$273.53 million
Share price: US$4.94

Late-stage biopharma company Rezolute is developing novel therapies targeting rare and chronic metabolic diseases. At the top of the company’s drug pipeline is RZ358, which is being studied for the treatment of congenital hyperinsulinism and tumor hyperinsulinism. The company also has RZ402, which is targeted for patients with diabetic macular edema.

RZ358 is currently in global Phase 3 clinical studies for congenital hyperinsulinism, with topline data expected in mid-2025. It opened to US participation in September after the US Food and Drug Administration (FDA) removed partial clinical holds.

In March, Rezolute shared results from a preclinical study that validated RZ358’s potential to treat patients with non-islet cell tumors that have uncontrolled hypoglycemia. Rezolute announced positive topline results for its Phase 2 study of RZ402 in May.

The company closed on a public offering with net proceeds of about US$56.4 million in June, which will help to fund post-phase 3 planning for its RZ358 program in congenital hyperinsulinism as well as a potential late-stage, registrational, clinical study of RZ358 in patients with tumor hyperinsulinism associated with islet cell and non-islet cell tumors.

In August, the FDA granted clearance for Rezolute’s investigational new drug application for a Phase 3 study of RZ358 in tumor hyperinsulinism. Patient enrollment is slated to begin in the first half of 2025.

This NASDAQ biotech stock had a great run up in the second quarter this year, posting a year-to-date high of US$6.09 on June 5.

3. Candel Therapeutics (NASDAQ:CADL)

Company Profile

Year-to-date gain: 346.31 percent
Market cap: US$213.52 million
Share price: US$6.66

Candel Therapeutics is another NASDAQ biotech company focused on developing oncology treatments. The company’s pipeline includes two clinical stage multimodal biological immunotherapy platforms.

Candel’s lead product candidate CAN-2409 is in a Phase 2 clinical trial in non-small cell lung cancer and borderline resectable pancreatic cancer, as well as Phase 2 and 3 trials for localized, non-metastatic prostate cancer. Positive interim data for the trial on pancreatic cancer, released on April 4, sent the company’s share price spiking upwards.

Its second lead product candidate is CAN-3110, which is in an ongoing Phase 1 clinical trial in recurrent high-grade glioma (HGG).

The company has had a number wins with the FDA this year. In February, Candel’s CAN-3110 received regulatory approval for a fast-track designation for the treatment of recurrent HGG. The agency also granted Candel orphan drug designation for CAN-2409 for the treatment of pancreatic cancer in April and CAN-3110 for HGG in May.

Candel is another NASDAQ biotech stock that had an excellent second quarter this year. After spiking on positive interim trial data for CAN-2409 in April, it continued climbing to hit a year-to-date high of US$14.30 on May 16.

4. Benitec Biopharma (NASDAQ:BNTC)

Company Profile

Year-to-date gain: 195.33 percent
Market cap: US$100.7 million
Share price: US$9.48

California-based Benitec Biopharma is advancing novel genetic medicines via its proprietary “Silence and Replace” DNA-directed RNA interference platform. The company is currently focused on developing therapeutics for chronic and life-threatening conditions including oculopharyngeal muscular dystrophy (OPMD). Its drug candidate BB-301 was granted orphan drug designation by the FDA and the European Medicines Agency.

In April, Benitec reported positive interim clinical trial data for its first OPMD subject treated with BB-301 in its Phase 1b/2a study. Following the report, Benitec’s share price began trending upward, and reached its then highest point in 2024 on May 20 at US$10.47 before falling back to US6.30 in late June. The company reported additional positive interim safety and efficacy data in mid-July, which boosted its share price once again to US$10.41 on July 16.

Benitec is well-funded to advance its BB-301 clinical development program through the end of 2025. The company’s share price hit its highest year-to-date value on October 1 at US$12.89.

5. Cardiol Therapeutics (NASDAQ:CRDL)

Press ReleasesCompany Profile

Year-to-date gain: 141.01 percent
Market cap: US$137.67 million
Share price: US$1.97

Biopharma company Cardiol Therapeutics is developing novel treatments for inflammation and fibrosis in cardiovascular conditions, including pericarditis, myocarditis, and heart failure.

The company has two drug candidates in its pipeline: CardiolRX, an orally administered cannabidiol under clinically studied for use in rare heart diseases, including recurrent pericarditis and acute myocarditis; and CRD-38, a drug formulation of cannabidiol that is administered subcutaneously for treating heart failure.

The FDA granted CardiolRx orphan drug designation in February. Cardiol released positive top-line results in mid-June for its Phase 2 open-label pilot study investigating the safety, tolerability and efficacy of CardiolRx in patients with recurrent pericarditis. The company believes the results will support moving the drug to Phase 3 clinical trials.

The positive news flow contributed to the strong momentum the stock has enjoyed this year, leading to a year-to-date share price high of US$3.12 on June 12.

An upcoming catalyst for Cardiol is the expected mid-November presentation of full clinical data for its aforementioned Phase 2 open-label study of CardiolRx for recurrent pericarditis.

Securities Disclosure: I, Melissa Pistilli, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Artificial intelligence (AI) may be an emerging technology, but there are plenty of billion-dollar companies in this space.

As the market has grown over the past few years, AI technology has made strong inroads into several key industries, including logistics, manufacturing, finance, healthcare, customer service and cybersecurity.

While AI-driven advancements in robotics have received the most press in recent years, the largest buzz has centered around OpenAI’s ChatGPT. This intelligent chatbot shows how quickly generative AI is advancing, and has attracted the attention of heavyweight technology companies such as Microsoft (NASDAQ:MSFT), which has reportedly invested billions of dollars in the privately held OpenAI. Alphabet (NASDAQ:GOOGL) has also released its own AI chat tool, Google Gemini.

On a global scale, Fortune Business Insights predicts that the AI industry will experience a compound annual growth rate of 20.4 percent between 2024 and 2032 to reach a market value of more than US$2.74 trillion.

American AI stocks

According to Tracxn Technologies, the number of US AI companies has more than doubled since 2017 with over 82,541 companies working in the sector today.

One of the major factors fueling growth in the American AI market, states Statista, is “the growing investments and partnerships among technology companies, research institutions, and governments.’

Below are three of the top US AI stocks organized by market cap.

1. Microsoft (NASDAQ:MSFT)

Company Profile

Market cap: US$3.188 trillion
Share price: US$428.91

In addition to the reported billions Microsoft is committed to investing in OpenAI, the technology behemoth has built its own AI solutions based on the chatbot creator’s technology: Bing AI and Copilot. OpenAI officially licensed its technologies to Microsoft in 2020.

An update to Windows 11 in 2023 integrated the Bing chatbot into the operating system’s search bar, allowing users to interact with the chatbot directly with Microsoft’s Edge browser, Chrome and Safari.

Microsoft’s moves into generative AI have translated into higher revenues for its Azure cloud computing business and a higher market capitalization as the tech giant pushed past the US$3 trillion mark in January 2024.

In late May, Microsoft unveiled its Copilot+ Windows PCs, the company’s first range of AI PCs, which the company says are the “fastest, most intelligent Windows PCs ever built.”

After receiving criticism over security flaws, Microsoft announced in late September that it has made changes to the Copilot+ exclusive Recall software, which uses AI to create screenshots of everything users do on their computers.

2. NVIDIA (NASDAQ:NVDA)

Company Profile

Market cap: US$2.95 trillion
Share price: US$120.05

The global leader in graphics processing unit (GPU) technology, NVIDIA is designing specialized chips used to train AI and machine learning models for laptops, workstations, mobile devices, notebooks, and PCs. The company is partnering with a number of big name tech firms to bring a number of key AI products to market.

Through its partnership with Dell Technologies (NYSE:DELL), NVIDIA is developing AI applications for enterprises, such as language-based services, speech recognition and cybersecurity. The chip maker has been instrumental in the build out of Meta Platforms’ (NASDAQ:META) AI supercomputer called the Research SuperCluster, which reportedly uses a total of 16,000 of NVIDIA’s GPUs.

In the first quarter, Taiwan Semiconductor Manufacturing Company (NYSE:TSM) and NVIDIA released the world’s first multi-die chip specifically designed for AI applications: the Blackwell GPU. Blackwell’s architecture allows for the increased processing power needed to train larger and more complex AI models.

In early June, NVIDIA saw its market cap zoom past the US$3 trillion mark to surpass that of Apple (NASDAQ:AAPL). On June 18, its valuation jumped to as high as US$3.34 trillion to briefly pass Microsoft before pulling back. In Q4 2024, the GPU giant is expected to produce 450,000 Blackwell AI chips worth a potential US$10 billion in revenue.

3. Alphabet (NASDAQ:GOOGL)

Company Profile

Market cap: US$2.03 trillion
Share price: US$164.29

Alphabet holds court with both Microsoft and NVIDIA as part of the tech sector’s Magnificent 7, and its foray into AI has similarly brought the tech giant much success. Alphabet’s market cap surpassed the US$2 trillion mark in April.

The company has its AI chatbot Gemini, formerly known as Bard, which is integrated into products such as its Google Suite, the Chromecast browser and Google Pixel phone line.

In early April, Google introduced a custom AI chip designed for its cloud services customers. Set to be delivered later this year, the technology uses British semiconductor company Arm Holding’s (NASDAQ:ARM) AI architecture. In the same week, Google revealed its new A3 Mega AI processor based on NVIDIA’s H100 Technology.

More recently, Google partnered with automaker Volkswagen (OTC Pink:VLKAF,ETR:VOW) to launch a smartphone app-integrated AI assistant for VW drivers.

Canadian AI stocks

Recognized as a world-leading AI research hub, Canada ranks eighth out of 83 countries in the Global AI Index. Since 2017, the Canadian government has invested hundreds of millions of dollars into accelerating the research and commercialization of AI technology in the country through the Pan-Canadian Artificial Intelligence Strategy.

Research by IBM (NYSE:IBM) says Canadian businesses are increasingly adopting AI, with 37 percent of IT professionals in large enterprises reporting that they have deployed the technology in their operations.

Below are three of the top Canadian AI stocks by market cap.

1. CGI (TSX:GIB.A)

Company Profile

Market cap: C$34.93 billion
Share price: C$154.55

Montreal-based CGI is among the world’s largest IT systems integration companies, and offers a wide range of services, from cloud migration and digital transformation to data analysis, fraud detection and even supply chain optimization. Its more than 700 clients span the retail, wholesale, consumer packaged goods and consumer services sectors worldwide.

Through a partnership with Google, CGI is leveraging the Google Cloud Platform to strengthen the capabilities of its CGI PulseAI solution, which can be integrated with existing applications and workflows.

CGI is aggressively working to expand its generative AI capabilities and client offerings, and is reportedly planning to invest US$1 billion into its AI offerings. In early March, the company launched Elements360 ARC-IBA, an AI powered platform for brokers and insurers to settle accounts in the UK broking industry.

In September, CGI signed the European Union’s Artificial Intelligence Act pledge to work for trustworthy and safe AI development.

2. OpenText (TSX:OTEX)

Company Profile

Market cap: C$12.15 billion
Share price: C$44.78

Ontario-based OpenText is one of Canada’s largest software companies. The tech firm develops and sells enterprise information management software. Its portfolio includes hundreds of products in the areas of enterprise content management, digital process automation and security, plus AI and analytics tools. OpenText serves small businesses, large enterprises and governments alike.

OpenText’s AI & Analytics platform has an open architecture that enables integration with other AI services, including Google Cloud and Azure. It can leverage all types of data, including structured or unstructured data, big data and the internet of things to quickly create interactive visuals.

Early in the year, OpenText launched its Cloud Editions 24.1, which includes enhancements to its OpenText Aviator portfolio.

‘Leveraging AI for impactful results depends on reliable data – without it, even the most skilled data scientists will struggle,” OpenText CEO and chief technology officer Mark J. Barrenechea stated. “By expanding the Aviator portfolio in conjunction with our world class information management platform, Cloud Editions 24.1 empowers customers with the tools and insights needed to get ahead.’

3. Descartes Systems Group (TSX:DSG)

Company Profile

Market cap: C$12.08 billion
Share price: C$138.10

Descartes Systems Group provides on-demand software-as-a-service (SaaS) solutions. The multinational technology company specializes in logistics software, supply chain management software and cloud-based services for logistics businesses.

AI and machine learning enhancements to Descartes’ routing, mobile and telematics suite are helping the company’s customers optimize fleet performance.

“AI and ML are perfect extensions to our advanced route optimization and execution capabilities,” Ken Wood, executive vice president at Descartes, said. “From dynamic delivery appointment scheduling through planning and real-time route execution, we’ve used AI and ML to improve our ability to deliver the next level of fleet performance for customers.”

Australian AI stocks

AI investment by Australian companies is projected to increase by 67 percent in 2024, according to BSI’s International AI Maturity Model, which would make the country the second best market in the world in terms of boosting AI capabilities. The biggest spenders when it comes to AI in Australia are the banking industry, the federal government, professional services and retail.

Below are three of the top Australian AI stocks by market cap.

1. Xero (ASX:XRO)

Company Profile

Market cap: AU$22.52 billion
Share price: AU$148.72

New Zealand-based technology company Xero provides cloud-based accounting software for small- and medium-sized businesses. The company’s product portfolio also includes the Xero Accounting app, Xero HQ, Xero Ledger, Xero Workpapers and Xero tax tools.

Xero has made a number of AI enhancements to its platform in recent years, including bank reconciliation predictions that save time and reduce errors, and Analytics Plus, a suite of AI-powered planning and forecasting tools.

In March, the company launched its Gen AI assistant, named Just Ask Xero, or JAX. Some of its features include the automation or streamlining of repetitive and time-consuming tasks; the ability to anticipate tasks based on previous user actions and the ability to make cashflow projections on request.

2. TechnologyOne (ASX:TNE)

Company Profile

Market cap: AU$7.84 billion
Share price: AU$23.80

TechnologyOne is another large enterprise technology software firm in Australia. In fact, it is the country’s largest enterprise resource planning SaaS company. TechnologyOne has a client base of over 1,200, including customers in the government, education, health and financial services sectors across Australia, New Zealand and the UK. The company’s research and development center is targeting cloud-based technology, artificial intelligence and machine learning.

Municipalities such as Shoalhaven in the UK are using TechnologyOne AI-based SaaS solutions to manage city services, including waste management and road maintenance.

TechnologyOne’s H1 2024 financial results for its fiscal period ended March 31 highlighted its 15th year of record first half revenue, profit and SaaS fees.

3. Weebit Nano (ASX:WBT)

Company Profile

Market cap: AU$351.38 million
Share price: AU$1.86

Israeli semiconductor IP company Weebit Nano develops silicon oxide-based resistive random-access memory (ReRAM) technologies. The company seeks to address the need for significantly higher-performance and lower-power computer memory technology.

Weebit’s products can be used to enable edge AI applications and AI systems such as neuromorphic computing. An advancement in AI and machine learning, neuromorphic computing is based on architectures designed to function in the same way as the human brain’s operation.

Weebit says its ReRAM cell “functions similarly to a synapse in the brain, making it a promising solution for neuromorphic computing.” The company is collaborating with research partners in academia and industry to further develop the use of ReRAM for neuromorphic computing.

FAQs for AI stocks

Which company is leading the AI race?

Google and Microsoft are battling it out for king of the AI hill. While Goldman Sachs sees Alphabet’s Google as leading the AI race, other analysts are pointing to Microsoft as the clear frontrunner. Microsoft stands to benefit in a big way from its billions of dollars investment in OpenAI’s ChatGPT as advancements in generative AI may have the potential to increase the company’s revenues for its Azure cloud computing business.

Which country is doing best in AI?

North America is the global hotspot for advancements in AI technology and is home to the majority of the world’s largest AI providers. Of the countries in this region, Canada’s AI industry is showing the fastest growth, according to a report by Deloitte. Techopedia positions the US as the primary hub for AI development, and many of the world’s leading tech giants are headquartered there. According to the report, China comes in a close second.

What is Elon Musk’s AI company?

In November 2023, Elon Musk launched Grok, a new AI technology company based in Nevada. Musk said he was starting it as a ‘third option’ to ChatGPT and Google Gemini. Its Grok chatbot, originally called TruthGPT, is included on Musk’s platform X, formerly known as Twitter.

Does Tesla have its own AI?

Tesla (NASDAQ:TSLA) has developed proprietary AI chips and neural network architecture. The company’s autonomous vehicle AI system gathers visual data in real time from eight cameras to produce a 3D output that helps to identify the presence and motion of obstacles, lanes and traffic lights. The AI-driven models also help autonomous vehicles make quick decisions. In addition to developing autonomous vehicles, Tesla is working on bi-pedal robotics.

Securities Disclosure: I, Melissa Pistilli, hold no direct investment interest in any company mentioned in this article.

2024 Tech Outlook Report

What red hot sector is expected to grow 85.7% annually until 2032?!

Download your investor report today.

Learn About Exciting Opportunities in the Tech Sector

Your Newsletter Preferences

This post appeared first on investingnews.com

Boss Energy Limited (ASX: BOE|OTCQX: BQSSF) is pleased to announce that its 30 per cent-owned Alta Mesa ISR Uranium Project in South Texas has been officially opened.

Boss attaches the Opening Announcement released by Alta Mesa’s 70 per cent owner enCore Energy Corp (NASDAQ:EU|TSXV: EU).

Please refer to enCore’s announcement dated October 8, 2024 for further information.1

This ASX announcement was approved and authorised by the Board of Boss Energy Limited.


For further information, contact:

Duncan Craib

Chief Executive Officer P: +61 (8) 6263 4494

E: boss@bossenergy.com


For media enquiries, contact:

Paul Armstrong Read Corporate

P: +61 (8) 9388 1474

E: info@readcorporate.com

Click here for the full ASX Release

This post appeared first on investingnews.com

White Cliff Minerals Limited (“the Company”) is delighted to announce the first batch of assay results from rock chip samples taken during the 2024 maiden field program at the Rae Copper Project in Nunavut, Canada (“Rae” or “the Project”). Results confirm outcropping and high-grade copper and precious metals hosted in extensive massive chalcocite vein systems of significant lateral extent.

Copper and silver assays received for three of the five exploration districts at RaeRepresentative rock samples from extensive outcropping massive chalcocite veins returned exceptional copper-silver ± gold and confirm what is now believed to be the first major discovery on the Company licence areaThe Vision District, a ±10km long NE/SW structural corridor which includes the Don and Pat project areas. Occurring within a “sub parallel, dilutional jog” that provided the necessary depositional environment for copper and precious metal accumulation. It is also possible, although yet to be proven, that these two project areas are contiguous, meaning the two localised ±km long zones of massive chalcocite may be one body up to ±5km in length. Recently flown geophysical surveys will confirm this either wayAt Don several parallel outcropping massive chalcocite veins running roughly NE/SW have been identified over an area of more than 2km2 and returned results of:

§64.02% Cu and 152g/tAg (4.88oz/t)

(F005965)

§62.02% Cu and 162g/tAg (5.20oz/t)

(F005966)

§50.48% Cu and 102g/tAg (3.28oz/t)

(F005959)

§43.77% Cu and 109g/tAg (3.50oz/t)

(F005958)

§39.68% Cu and 91g/t Ag (2.92oz/t)

(F005971)

§39.10% Cu and 102g/tAg (3.28oz/t)

(F005964)

§36.70% Cu and 223g/tAg (7.16oz/t)

(F005975)

§9.57% Cu, 2.34g/t Au and 128g/tAg (4.12oz/t)

(F005974)

At Pat, ±4.4km along strike from DON & around 600m of visual outcrop, returned assays of:

§55.01% Cu and 37g/tAg

(F005977)

§46.07% Cu and 46g/tAg

(F005984)

§44.43% Cu and 32g/tAg

(F005979)

§43.10% Cu and 44g/tAg

(F005985)

§41.26% Cu and 34g/tAg

(F005978)

§39.90% Cu and 34g/tAg

(F005986)

The Company’s primary focus, Hulk, a large scale sedimentary hosted copper target, is a 16x4km magnetic anomaly within the reactive basal sequence of the Rae Group sedimentary basin which has been identified coincident with extensive surface staining of malachite with one sample, F005987, returning 1.65% Cu. The identification of copper in this area provides geological proof for the first time that copper rich hydrothermal fluids have in fact permeated the sedimentary basin. This geological environment is considered a high priority for drillingRemaining assay results (41 samples) from the Thor and Rocket Districts are expected are over the coming weeksThe Project saw the completion of one of Canada’s largest aerial geophysical survey’s covering 2,500 line-km of MobileMT geophysics, marking the first license scale survey completed in history at the Project with these results due during the December quarter

The Rae Copper Project is extraordinary in scope and scale. Having undertaken an extensive internet search, it is my belief that these results are the highest ever recorded copper assays from a representative rock chip sample anywhere in the world and in fact are approaching the stoichiometric maximum copper can reach in an ore forming mineral.

White Cliff’s Great Bear Lake Project potentially holds the mantle of the highest ever recorded representative Silver rock sample assay result of 7.54% Ag and now, the Rae Project can lay claim to the highest ever recorded representative Copper rock sample assay.

The results also demonstrate the deep plumbing, copper rich fluids & fertile nature of the host rocks of basal part of the Rae sedimentary sequence and provide longer-term opportunities for not just bulk tonne sedimentary hosted copper but potential for direct shipping of a high-grade copper concentrate using a mine and ship approach from these newly identified chalcocite veins.

In the next months the company expects to receive the MobileMT geophysical results which will sharpen the resolution of the previous groundwork, confirming drilling targets for the upcoming campaign, which will include the priority – Hulk, a very large, green at surface, 16km by 4km target within the reactive subsurface basal units (siltstones and mudstones) of the Rae Sedimentary Basin, this basin has been intersected by similar mineralising regional structures proven to be copper conduits including those seen at Vision.

These two projects are proving to be world class exploration opportunities. Rae and Great Bear are located in a tier one mining and investment jurisdiction, on the mainland, with significant infrastructure already in place.”

Troy Whittaker – Managing Director

“The team at WCN have built a solid foundation of high-quality projects through old school geological hard work. Results of this nature are rare and to have them repeated over some distance is very encouraging. I look forward to the upcoming work as we prepare for drilling.”

John Hancock – Strategic Advisor to the Board

Click here for the full ASX Release

This post appeared first on investingnews.com

Mohammad Sultan, 28, said he and his family fled their house in Jabalya in northern Gaza “due to the intense and continuous bombardments in the area.” When he went back to retrieve food, water and blankets, he and other civilians were fired at, he said.

Footage taken by Sultan during his journey shows residents walking along a sandy road, surrounded by rubble and half-destroyed buildings. Some, including children, are on foot, struggling to walk with heavy bags. Others are on bicycles or tuk-tuks.

Drones can be heard buzzing in the background as the bullwhip-like sound of bullets piercing the air trigger screams and attempts to shelter.

The Israeli military on Monday issued fresh evacuation orders in both northern and southern Gaza, where tens of thousands of Palestinians have been sheltering. In northern Gaza, the military said it is “currently operating with great force in the area” and told residents to move to Al Mawasi, a southern region designated as a so-called humanitarian zone that is already crammed with refugees.

A day earlier, Israel’s military said it had encircled Jabalya as it launched a new ground operation there amid efforts by Hamas to “rebuild its operational capabilities in the area.”

Hamas’s military wing, Al-Qassam Brigades, said on Monday it was engaged in “fierce fights” with Israeli forces in northern Gaza.

The renewed fighting comes on the first anniversary of the October 7 attacks by Hamas.

Gunfire at ‘anything that moves’

“We stayed in the house to search for the remaining body parts of Hassan, but now we cannot go out due to the intensity of the shelling and gunfire,” the 58-year-old said, adding the gunfire targets “anything that moves.”

“We try to stay away from the windows, so they won’t shoot at us,” she said.

Residents say the fighting in Jabalya has been some of the most intense in recent days.

Mohammad Ibrahim, a resident of the city who decided to stay in his home with his two sons, said the explosions outside his house were so intense they “shook” his body.

From his window, Ibrahim said he could see smoke billowing between abandoned apartment buildings. “Anyone who wants to leave the north to Gaza wants death,” he said.

Jabalya has been targeted several times during the war, and like many other parts of Gaza, its residents say they don’t know where to go for shelter.

“We are living in the Stone Age,” Ibrahim said. “There is no conscience, no humanity, no human rights.”

This post appeared first on cnn.com

A man has been charged for the rape and murder of a resident doctor during a night shift in India’s eastern city of Kolkata, a crime that ignited nationwide protests about the country’s pervasive problem with gender violence.

The resident doctor’s body was found the following day with multiple injuries and signs of sexual assault in a seminar hall at the hospital, local police said at the time.

The doctor trainee was resting in a seminar room at the medical college while working a night shift when the attack occurred, Kolkata’s then-police commissioner Vineet Kumar Goyal said in August. By Indian law, rape victims cannot be named.

Evidence presented by CBI, according to the charge sheet, include CCTV footage of the man at the hospital at the time of the incident and DNA found on the victim that matches that of the suspect.

Protests and strikes

India has struggled for years to tackle high rates of violence against women, with a number of high-profile rape cases drawing international attention.

In the weeks after the alleged attack, hundreds of thousands of doctors have joined nationwide protests demanding justice and calling for improvements to women’s safety, especially better protections for health workers.

Medical bodies in multiple states have expressed support for the protests in Kolkata and urged doctors at government hospitals to stop providing elective services, calling for the case to be fast-tracked through the courts and for the establishment of a protective committee for health workers.

One of the nation’s top medical bodies, the Federation of All India Medical Association (FAIMA), said it will also carry out a hunger strike on Wednesday, which marks two months since the trainee doctor’s death.

“This ongoing violence highlights the urgent need for stronger protective measures and central legislation dedicated to safeguarding healthcare professionals,” FAIMA said in its statement.

Last month, the West Bengal government said they would meet some of protesters’ demands, including replacing the Kolkata police commissioner, deputy commissioner and two senior government health officials over the incident.

The state government also directed state-run hospitals to avoid putting female doctors on night duty, a decision slammed by the country’s Supreme Court, arguing they need security and not concessions. The measure was later revoked.

Two other people, the medical college’s former principal and a police officer were also arrested last month in connection to the case, the source from the CBI said.

“Amongst other things, they have been accused of compromising the scene of the crime and the delay of the registration of an FIR (First Information Report),”the source said, adding that their role is being investigated.

Many of the doctors who are protesting have highlighted incidents of violence toward health workers and threats of physical abuse by angry patients or their family members.

A survey in 2015 by the Indian Medical Association found 75% of doctors in India had faced some form of violence, local media reported at the time.

One of the country’s most infamous rape and murder cases to spark huge demonstrations and public anger was the 2012 gang-rape of a medical student who was beaten, tortured and left to die following a brutal attack on a public bus in New Delhi.

The case and ensuing nationwide protests drew international media scrutiny – and prompted authorities to enact legal reforms. The rape law was amended in 2013 to broaden the definition of the crime and set strict punishments not only for rape but also for sexual assault, voyeurism, and stalking.

Despite these changes, rape cases remain prevalent in the country, with victims and advocates saying the government is still not doing enough to protect women and punish attackers.

According to India’s National Crime Records Bureau, a total of 31,516 rape cases were recorded in 2022, an average of 86 cases per day.

Experts warn that the number of cases recorded are a fraction of what may be the real number, in a deeply patriarchal country where shame and stigma surround rape victims and their families and where cases face delays and backlogs in court, denying victims justice or closure.

This post appeared first on cnn.com